{
    "2019-05-24": [
        [
            {
                "time": "",
                "original_text": "业绩持续增长、机构重仓持有股溢价空间更高",
                "features": {
                    "keywords": [
                        "业绩",
                        "增长",
                        "机构重仓",
                        "溢价空间"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "产业观察|困在南边的片仔癀",
                "features": {
                    "keywords": [
                        "片仔癀",
                        "产业观察",
                        "困境"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报:积极关注医疗信息化、国企改革投资主线",
                "features": {
                    "keywords": [
                        "医药行业",
                        "医疗信息化",
                        "国企改革",
                        "投资主线"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "投入需加强？ A股年入50亿药企仅4家研发占收入比超10%",
                "features": {
                    "keywords": [
                        "研发投入",
                        "A股",
                        "药企",
                        "收入比"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "起底“暴力抗法”的深大通：去年净亏23亿 曾险退市 亏损",
                "features": {
                    "keywords": [
                        "深大通",
                        "暴力抗法",
                        "净亏",
                        "退市风险"
                    ],
                    "sentiment_score": 0.1,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}